Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity

Area of Science:

• Neuroimmunology
• Pharmacology
• Autoimmune Diseases

Background:

• Daphnetin, a coumarin derivative, exhibits anti-inflammatory and immunosuppressive properties.
• Previous studies suggest daphnetin can suppress neuroinflammation, indicating potential for treating neuroinflammatory diseases.
• Multiple sclerosis (MS) is a T helper (Th) cell-mediated autoimmune disease affecting the central nervous system (CNS).

Purpose of the Study:

• To investigate the therapeutic potential of daphnetin in experimental autoimmune encephalomyelitis (EAE), an animal model for MS.
• To determine if daphnetin treatment can protect mice against EAE-induced neuroinflammation and demyelination.
• To elucidate the mechanisms by which daphnetin affects immune cell responses, particularly T cells and dendritic cells.

Main Methods:

• EAE mice were induced and treated with daphnetin (8 mg/kg) for 28 days.
• Histopathological analysis assessed neuroinflammation and demyelination in spinal cords.
• Immunohistochemistry and ELISA were used to evaluate T cell infiltration and cytokine production.
• Dendritic cell (DC) activity, including surface marker expression, cytokine secretion, and T cell activation, was assessed.
• Molecular mechanisms, including NF-κB signaling and heme oxygenase-1 induction, were explored.

Main Results:

• Daphnetin treatment significantly alleviated clinical symptoms of EAE, reducing CNS inflammation and demyelination.
• Th1 and Th17 cell responses were markedly suppressed in daphnetin-treated mice.
• Daphnetin inhibited DC activation, maturation, and antigen-presenting capacity.
• NF-κB signaling was reduced in DCs, with increased heme oxygenase-1 expression.

Conclusions:

• Daphnetin demonstrates efficacy in ameliorating EAE by modulating DC function and subsequent T cell responses.
• The findings suggest daphnetin regulates dendritic cell function and T helper cell development.
• Daphnetin represents a potential novel, safe, and effective therapeutic agent for autoimmune neuroinflammation due to its low toxicity.